On Growing Opportunities in Medical & Industrial Tech Markets Panel at 1 pm ET on March 21st
CALGARY, AB, March 16, 2023 /PRNewswire/ – Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) (“Nanalysis” or the “Company”) announces that Company CEO Sean Krakiwsky has been invited to present on the panel “Growing Opportunities in Industrial & Medical Markets” at the Industrial Tech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, March 21st 2023 at 1:00 p.m. ET.
New technology combined with emerging trends in multiple industrial sectors will continue to create both opportunities and challenges for most of the companies participating in our virtual industrial conference. These companies are introducing new technology into industrial end markets for multiple reasons, including to improve the resiliency of water infrastructure or manufacturing. Our company introductions and panel discussions with CEOs will highlight emerging sector trends and margin and revenue opportunities driven by new technology.
This conference will be live on M-Vest. To attend, just sign up to become an M-Vest member.
Click Here to Reserve your seat
Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol ‘NSCI’, OTC under NSCIF, and the Frankfurt exchange under the ticker symbol ‘1N1’. The company’s business is what we term “MRI and NMR for industry”. The company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis began selling a 100MHz device in 2020. The Company’s new device is the most powerful and most advanced compact NMR device ever brought to market. Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.
With the recent acquisition of K’Prime, the Company maintains a North American sales and service company of over 40 individuals who cover scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems and services for security applications. Additionally, the Company has a 43% ownership in Quad Systems AG (“Quad Systems”), with an option to purchase the remaining shares. Quad Systems is a Zurich-based Nuclear Magnetic Resonance (“NMR”) company focused on high-field NMR for pharmaceutical and other vertical markets.
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “anticipates”, “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, “positioned” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
SOURCE Nanalysis Scientific Corp.
